『AI Investment Edge: Stocks, Markets & Money』のカバーアート

AI Investment Edge: Stocks, Markets & Money

AI Investment Edge: Stocks, Markets & Money

著者： iPulse AI by Future Edge Group
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
Clear, evidence-led conversations about AI investment research, stock theses, and the assumptions behind market forecasts. From iPulse AI, the Open Agentic Investment Research Platform by Future Edge Group: explore the sources and dated research at https://ipulseai.com. Research, not investment advice.

ipulseai.substack.comRusslansing Ramdowar 個人ファイナンス 経済学
エピソード
  • Novo Nordisk: Huge Demand, Harder Profits | EP024

    Novo Nordisk: Huge Demand, Harder Profits | EP024
    2026/10/18
    Huge demand. A harder profit equation.More patients do not automatically mean stronger shareholder returns. Novo Nordisk must turn expanding access and manufacturing capacity into earnings and cash while prices, competition and research costs press in.This episode follows Novo Nordisk’s ordinary B share, NOV.XETRA/EUR (ISIN DK0062498333). The reference is €34.80, the provider daily close dated 16 October 2026, refreshed on 18 October. The database updated at 21:16 Dubai on 16 October; that is an update time, not a supplied trade minute. Copenhagen’s DKK share quote and the NYSE ADR are separate references.What Novo sellsNovo Nordisk is a Danish pharmaceutical company supplying diabetes, obesity and rare-disease medicines, including Ozempic, Wegovy and insulin products. Wegovy now includes injectable and marketed oral products; the US pill launch was in January 2026. Patients, prescribers, insurers and public health systems shape access and realized prices. Clinical research and manufacturing remain central costs.Four financial findings* Earnings: H1 reported sales of DKK175.3bn and operating profit of DKK86.7bn include a DKK26.8bn noncash US340B rebate provision reversal. Adjusted sales were DKK148.6bn and adjusted operating profit DKK66.2bn; each grew 2% at constant exchange rates. Q2 also included DKK6.3bn of noncash pipeline impairments. Removing an accounting item does not erase its economic significance.* Margins: H1 adjusted operating margin was 44.6%. Adjusted gross margin fell to 79.3% from 83.1%, with lower prices, capacity-agreement changes and FX partly offset by productivity and product mix.* Balance sheet: June company-defined net debt was DKK86.5bn, excluding lease liabilities; cash at bank was DKK44.5bn. Cash generation, debt, research, investment and distributions must be considered together.* Investment: H1 operating cash flow of DKK79.3bn less PP&E purchases of DKK24.0bn produced DKK55.3bn of company-defined free cash flow. Payment timing and expense phasing helped. This definition changed in 2026, with comparatives restated. Annual guidance is around DKK55bn PP&E spending and DKK45–55bn free cash flow; doubling the half-year cash figure would misrepresent the outlook.The 2026 adjusted sales and operating-profit growth outlook is −6% to 0% at constant exchange rates. September Capital Markets Day describes lower future capex intensity and broadly stable adjusted operating margins by 2030 as ambitions, not achieved results or guaranteed guidance. No freshly validated normalized P/E is supplied here.Fixed-date price scenarios from €34.80The September research endpoints remain 18 September 2027 and 18 September 2031—about 11 months and 4 years 11 months from this episode. Returns below are cumulative price changes, excluding dividends. These are conditional scenarios, not achieved returns or calibrated probabilities.Evidence-weighted base: 18 Sep 2027 €43.81 (+25.9% price); 18 Sep 2031 €69.60 (+100.0% price).Separate simple-averaged bull: 18 Sep 2027 €52.53 (+50.9% price); 18 Sep 2031 €88.72 (+154.9% price).Separate simple-averaged middle: 18 Sep 2027 €44.72 (+28.5% price); 18 Sep 2031 €74.09 (+112.9% price).Separate simple-averaged bear: 18 Sep 2027 €37.02 (+6.4% price); 18 Sep 2031 €48.43 (+39.2% price).The evidence-weighted base aggregates research forecasts; its weights are not calibrated outcome probabilities. The public averaged table uses a different aggregation from the evidence-weighted base. Its displayed endpoint prices are rounded; its returns above are recalculated from those displayed prices. A positive modeled bear is not a loss floor. Volume, pricing, clinical outcomes and capacity returns can develop outside these assumptions.Dividend cash: amounts, timing and FXDividends are normally unequal payments twice yearly. The latest interim was DKK3.75 per ordinary share, with a payment date of 18 August 2026; the previous final of DKK7.95 was paid on 31 March 2026. Both are already past. DKK11.70 is an unchanged annual illustration, not a declared future total.Assuming unchanged future March finals and August interims gives one future cycle, DKK11.70, before 18 September 2027 and five cycles, DKK58.50, before 18 September 2031. At the explicit fixed ECB 16 October reference of DKK7.4748 per €1, that is €1.565259 and €7.826296 per share (about €1.57 and €7.83). Adding this assumed cash once to the weighted price endpoints gives +30.4% and +122.5% cumulative cash-inclusive base returns. These are gross before investor taxes and fees, without reinvestment and at constant illustrative FX. Future dividends and exchange rates can differ. Buybacks are separate.What could close—or widen—the gap?The thesis tests whether more patients and better factory utilization can outweigh net-price erosion. Drivers include oral and injectable reach, throughput and clinically supported indications. Frictions include rebates, competition, depreciation, ...
    続きを読む 一部表示
    22 分
  • SpaceX: The Next Revolution—At What Price? | EP023

    SpaceX: The Next Revolution—At What Price? | EP023
    2026/10/17
    SpaceX: The Next Revolution—At What Price? | EP023Starlink is generating operating profit while SpaceX invests heavily in AI infrastructure. Can growing revenue and useful capacity produce enough cash to support the price?SpaceX is the listed parent behind reusable launch services, Starlink connectivity and an AI business including Grok, X and Cursor. Explore the SpaceX research and complete forecast, individual AI opinions, forecast history and methodology.SpaceX’s next-revolution ambitionSpaceX is developing Starmind: solar-powered AI computing in orbit, connected through its satellite network. Its SEC-filed strategy includes orbital AI, and NVIDIA’s August announcement describes first-generation Starmind development. This planned orbital business sits alongside its current AI infrastructure buildout. The investment question is how efficiently those ambitions turn capital into useful capacity and cash returns.Price and cumulative expectationsSPCX (Nasdaq), Class A common shares, USD 146.37: latest available Alpaca IEX after-hours trade, 16 October 2026 at 16:59:47 New York / 00:59:47 Dubai on 17 October. This is a dated IEX trade, not a consolidated official close. The evidence-weighted base case is −1.1% to 18 September 2027 and +48.1% to 18 September 2031. These are cumulative price changes from USD 146.37. The base targets are USD 144.829776 / USD 216.744413.No regular common cash dividend is paid or modeled; annual and modeled future cash dividends are zero, with no dividend uplift. Bull and bear cases are qualitative: faster capital payback and commercial adoption versus persistent investment, pricing/collection pressure and valuation compression. Consistent numerical consensus bull/bear endpoints are unavailable, so those cases focus on operating mechanisms.Four financial findingsEarnings: Q2 revenue USD 7.814 billion, up 91.9%; GAAP net loss USD 541 million. Margins: Connectivity operating income USD 1.656 billion, Space operating loss USD 542 million and AI operating loss USD 1.257 billion combine to group operating loss USD 143 million. Positive adjusted EBITDA adds back costs including depreciation, amortization and share-based compensation; it is a different non-GAAP measure, rather than segment cash flow.Balance sheet: June 30 cash USD 93.522 billion plus marketable securities USD 6.487 billion, versus USD 39.364 billion debt and finance leases. This supports investment capacity but does not establish operating self-sufficiency. Investment: Q2 capex USD 18.369 billion comprised USD 15.828 billion AI, USD 1.367 billion Connectivity and USD 1.174 billion Space. About 86% was AI. H1 operating cash3.466bn minus28.476bn gross PP&E purchases gives a derived25.010bn cash-investment gap before separate rebates/other investing flows; this is not management-defined free cash flow.These findings combine the four released financial consensus reviews with primary filings. Satellite renewal, growth investment and AI compute have different economics. An estimated accounting useful life is not a universal physical expiry. Connectivity profit is not a disclosed segment cash-flow statement.What happens next?SpaceX announced Q3 results after the US close on 20 October 2026. The webcast is that same US day at 16:30 New York, equivalent to 00:30 Dubai on 21 October. The next tests are AI infrastructure revenue and collection, Starlink subscriber/enterprise economics, capex, financing commitments and per-share value. Cursor closed 14 August in a principally equity transaction. The company reports that Flight 14 on 28 September delivered 26 V3 satellites on Starship’s first orbital flight; routine rapid full reuse and target cost savings remain separate execution tests.The thesis and its testsRecurring connectivity, reusable launch and sovereign demand support the business. Investment absorption, pricing, share supply and spectrum/orbital coordination constrain the equity case. Larger mobile connectivity and orbital services are upside tails; debris damage and extended Starship delays are downside tails. A Starship setback does not automatically ground all Falcon launches or destroy the existing network. The hinge is cash after investment alongside useful capacity and customer receipts.The September panel contains 14 contributions across 9 framework families and 3 model versions; 12 contributions use the same Gemini version. July contained 12 contributions on one model version, so changes in the panel are separate from changes in the business. The original score and raw syntheses remain inspectable; primary checks correct factual overstatements without rewriting the governed research. Upstream source/manual display QA remains open.Complete evidence-weighted base pathAll returns below use USD 146.37; endpoints are fixed model review windows, not company deadlines.* 2026-12-18: -1.2% cumulative price return.* 2027-03-18: -4.6% cumulative price return.* 2027-06-18: -3.9% cumulative price return.* 2027-09...
    続きを読む 一部表示
    22 分
  • Tesla: Roadster Thrills. Can the Cash Follow? | EP 022

    Tesla: Roadster Thrills. Can the Cash Follow? | EP 022
    2026/10/16
    Tesla: Roadster Thrills. Can the Cash Follow? | EP 022Tesla’s flying Roadster puts extraordinary engineering on display. The investment test is whether cars, storage and AI can generate enough cash to justify the price and fund the buildout.Tesla sells electric vehicles, Megapack and Powerwall storage, charging, services and software. Explore the Tesla analysis and forecast history and iPulse AI methodology.The Roadster revealTesla’s official event began at 04:55 Dubai on 16 October, the evening of 15 October in Texas. Its replay includes ramp, kickflip and acceleration demonstrations. The new angular silver-white Roadster combines active aero, suction and optional cold-gas thrusters. Tesla describes Performance and Thrust as two-seat versions; the invite-only Rocket seats one and is not approved for public-road use. The presenters reported 0.81 seconds for an acceleration run and a 2028 production target. These are Tesla’s demonstration report and target. The cover is an editorial illustration of the new airborne Roadster with fictional presenters.Price and cumulative scenariosTSLA.NASDAQ common shares, USD 368.13: an Alpaca IEX trade timestamped 16 October 2026 at 10:15:20 New York/18:15:20 Dubai. The same price is used for every percentage below. Endpoints remain 18 September 2027 and 18 September 2031.* Base: −15.9% to September 2027; −4.9% to September 2031.* Bull: −2.1% to September 2027; +57.7% to September 2031.* Bear: −32.7% to September 2027; −58.3% to September 2031.The main conversation uses the public averaged scenario table consistently: base targets 309.71/349.92, bull 360.51/580.39, bear 247.60/153.34 USD. Tesla pays no cash dividend; annual and modeled future cash dividends are zero, so no dividend uplift is added. These are cumulative price scenarios to the stated dates.Four financial findingsEarnings. Q2 revenue rose 26% to USD 28.236 bn, but operating income fell 57% to USD 398 m. After-tax GAAP common-stockholder net income was USD 1.114 bn. A separate pretax USD 1.005 bn unrealized SpaceX investment gain sits below the operating line. Taxes and other non-operating items bridge operating income to after-tax net income; the pretax mark cannot be equated with virtually all after-tax earnings. The noncash mark boosted earnings without adding operating cash.Margins. Q2 operating margin was 1.4%, versus 4.1% a year earlier; gross margin was 16.8%. Revenue growth and profitable growth are separate tests.Balance sheet. June cash, equivalents and short-term investments totalled USD 43.524 bn; debt and finance leases totalled USD 9.342 bn. Liquidity funds the transition while investment and operating obligations compete for cash.Investment. Q2 operating cash USD 4.697 bn less capex USD 5.789 bn left negative USD 1.092 bn free cash flow. First-half cash flow USD 8.634 bn less capex USD 8.282 bn left positive USD 352 m. Current 2026 total-company capex guidance exceeds USD 25 bn, spanning AI compute, data centres, manufacturing and other assets. Periods and cash flow measures are not interchangeable.These financials cover the quarter ended 30 June, released 22 July. Q3 operations announced 2 October were 486,532 deliveries, 464,391 vehicles produced and 13.7 GWh storage deployed. Q3 financial results are scheduled 21 October after the US close; Q&A 17:30 New York/01:30 Dubai on 22 October.What would change the thesis?Watch automotive margin recovery, storage profit and utilisation, recurring software cash, robotaxi operating costs, and cash generation relative to the capital programme. The bull needs commercial economics to follow engineering; the bear centres on margin pressure, investment absorption and valuation compression. Supply disruption and autonomy liability are concrete tail risks; broader authorised deployment and useful robotics are upside mechanisms.Complete averaged scenario pathAll percentage changes below are from USD 368.13, excluding dividends.* 2026-12-18: bear -18.9%, base -7.8%, bull -5.0%.* 2027-03-18: bear -31.0%, base -13.4%, bull -4.6%.* 2027-06-18: bear -27.9%, base -14.7%, bull -6.2%.* 2027-09-18: bear -32.7%, base -15.9%, bull -2.1%.* 2027-12-18: bear -36.1%, base -16.3%, bull +1.8%.* 2028-03-18: bear -40.6%, base -18.3%, bull -1.6%.* 2028-06-18: bear -38.8%, base -16.0%, bull +3.2%.* 2028-09-18: bear -42.5%, base -15.8%, bull +8.4%.* 2028-12-18: bear -39.6%, base -15.4%, bull +11.6%.* 2029-03-18: bear -43.8%, base -15.6%, bull +12.9%.* 2029-06-18: bear -46.7%, base -12.8%, bull +19.7%.* 2029-09-18: bear -49.9%, base -13.3%, bull +23.3%.* 2029-12-18: bear -48.9%, base -12.2%, bull +28.2%.* 2030-03-18: bear -51.4%, base -11.5%, bull +32.1%.* 2030-06-18: bear -53.4%, base -10.2%, bull +37.3%.* 2030-09-18: bear -55.7%, base -10.0%, bull +40.1%.* 2030-12-18: bear -54.4%, base -7.7%, bull +45.3%.* 2031-03-18: bear -56.2%, base -8.0%, bull +50.1%.* 2031-06-18: bear -57.5%, base -5.9%, bull +53.1%.* 2031-09-18: bear -58.3%, base -4.9%, bull +57.7%....
    続きを読む 一部表示
    25 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません